We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Guidant in January 2005 chose not to alert physicians about electrical flaws in two heart defibrillators when the company knew of the defects, allowing patients to continue being implanted with the faulty devices, according to recently released documents.
Two Israeli companies, OrSense and Glucon have presented good results of clinical tests at the American Diabetes Association's 66th Scientific Sessions, in Washington, D.C.
"Several emerging-growth companies in the durable medical equipment (DME) sector may be logical acquisition candidates as the momentum toward consolidation within the DME sector continues," stated SmallCap Sentinel analyst D.R. Clark. "
Irvine, Calif., USA. Dermisonics, Inc. has reduced the manufacturing costs of the ultrasonic transducer for its needle-free and painless drug injection device.
St. Jude Medical, Inc. today announced European CE Mark approval of its newest devices for treating patients with potentially lethal heart arrhythmias and heart failure.
A test to measure heartbeat fluctuations may improve the cost effectiveness of at least one type of heart therapy in patients at heightened risk for life-threatening cardiac events, Cambridge Heart has announced.